NO922226L - 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater - Google Patents

7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater

Info

Publication number
NO922226L
NO922226L NO92922226A NO922226A NO922226L NO 922226 L NO922226 L NO 922226L NO 92922226 A NO92922226 A NO 92922226A NO 922226 A NO922226 A NO 922226A NO 922226 L NO922226 L NO 922226L
Authority
NO
Norway
Prior art keywords
carboxylic acid
acid derivatives
navythyridon
quinolon
isoindolinyl
Prior art date
Application number
NO92922226A
Other languages
English (en)
Norwegian (no)
Other versions
NO922226D0 (no
Inventor
Uwe Petersen
Andreas Krebs
Thomas Schenke
Franz Kunisch
Thomas Philipps
Klaus Grohe
Klaus-Dieter Bremm
Rainer Endermann
Karl-Georg Metzger
Ingo Haller
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO922226D0 publication Critical patent/NO922226D0/no
Publication of NO922226L publication Critical patent/NO922226L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92922226A 1991-06-22 1992-06-05 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater NO922226L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120646A DE4120646A1 (de) 1991-06-22 1991-06-22 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate

Publications (2)

Publication Number Publication Date
NO922226D0 NO922226D0 (no) 1992-06-05
NO922226L true NO922226L (no) 1992-12-23

Family

ID=6434522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922226A NO922226L (no) 1991-06-22 1992-06-05 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater

Country Status (20)

Country Link
US (1) US5464796A (zh)
EP (1) EP0520240A1 (zh)
JP (1) JPH05239051A (zh)
KR (1) KR930000503A (zh)
CN (1) CN1068115A (zh)
AU (1) AU648669B2 (zh)
CA (1) CA2071677A1 (zh)
CZ (1) CZ190192A3 (zh)
DE (1) DE4120646A1 (zh)
FI (1) FI922873A (zh)
HU (1) HUT62288A (zh)
IE (1) IE922003A1 (zh)
IL (1) IL102261A (zh)
MX (1) MX9202982A (zh)
NO (1) NO922226L (zh)
NZ (1) NZ243214A (zh)
PH (1) PH30227A (zh)
RU (1) RU2056411C1 (zh)
SK (1) SK190192A3 (zh)
TW (1) TW202442B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19500792A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DE19506535A1 (de) * 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
DE19512484A1 (de) * 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
MY138335A (en) * 1997-09-15 2009-05-29 Procter & Gamble Antimicrobial quinolones, their compositions and uses
PA8466701A1 (es) 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7220824B1 (en) 2000-08-28 2007-05-22 Bayer Aktiengesellschaft Integrin-mediated drug targeting
EP1219634A1 (en) * 2000-12-27 2002-07-03 Bayer Aktiengesellschaft Cytostatic-glycoconjugates having specifically cleavable peptidic linking units
EP1238678A1 (en) 2001-03-08 2002-09-11 Bayer Aktiengesellschaft Enzyme-activated cytostatic conjugates with integrin ligands
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
MX2008012328A (es) * 2006-03-28 2008-10-09 Procter & Gamble Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico.
JP2009531418A (ja) * 2006-03-28 2009-09-03 ザ プロクター アンド ギャンブル カンパニー キノロン中間体調製のためのカップリング方法
KR100690084B1 (ko) * 2006-11-01 2007-03-09 주식회사 세홍이엔씨 출입문과 연동하는 주택 내 배전반
WO2013111158A2 (en) * 2012-01-03 2013-08-01 Msn Laboratories Limited Process for the preparation of dpp-iv inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
EP0154780B1 (en) * 1984-01-26 1990-04-11 Abbott Laboratories Quinoline antibacterial compounds
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
WO1990012799A1 (en) * 1989-04-26 1990-11-01 The Upjohn Company Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines

Also Published As

Publication number Publication date
AU1739192A (en) 1992-12-24
TW202442B (zh) 1993-03-21
AU648669B2 (en) 1994-04-28
JPH05239051A (ja) 1993-09-17
EP0520240A1 (de) 1992-12-30
US5464796A (en) 1995-11-07
HU9202085D0 (en) 1992-09-28
IL102261A0 (en) 1993-01-14
CN1068115A (zh) 1993-01-20
RU2056411C1 (ru) 1996-03-20
PH30227A (en) 1997-02-05
SK190192A3 (en) 1995-08-09
FI922873A0 (fi) 1992-06-18
MX9202982A (es) 1992-12-01
CZ190192A3 (en) 1993-01-13
NZ243214A (en) 1995-07-26
FI922873A (fi) 1992-12-23
KR930000503A (ko) 1993-01-15
IE922003A1 (en) 1992-12-30
CA2071677A1 (en) 1992-12-23
HUT62288A (en) 1993-04-28
DE4120646A1 (de) 1992-12-24
IL102261A (en) 1996-10-16
NO922226D0 (no) 1992-06-05

Similar Documents

Publication Publication Date Title
NO922226L (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
EE9900248A (et) 7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe- ja -naftüridoonkarboksüülhappederivaatide kasutamine Helicobacter pylori infektsioonide ja sellega assotsieeruvate gastroduodenaalhaiguste teraapiaks
NO20044633L (no) Nye alkoksypyridinderivater
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
AU6307586A (en) Quinoline derivatives
AU1835988A (en) New derivatives of substituted pyridine-3-carboxylic acid and use thereof
SE7810295L (sv) Substituerad kinolinkarboxylsyra
ES2001852A6 (es) Procedimiento para preparar un derivado de acido quinolocarboxilico
SE8001689L (sv) 6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
ATE170861T1 (de) Antibiotische carbapenemderivate
NO824304L (no) Fremgangsmaate for fremstilling av antibakterielle pencillinderivater
DE3650221T2 (de) Penemderivate.
AU562643B2 (en) N-arylpiperazine derivatives
SE8601963L (sv) O-sulfaterade beta-laktamhydroxamsyror
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
ES2010462A6 (es) Procedimiento para obtener ciprofloxacina.
GB1449159A (en) Benzoisoindoline derivatives
ES2009936A6 (es) Procedimiento para obtener ciprofloxacina.
FI923128A (fi) 3-piperazinylbensazolderivat.